<div id="readability-page-1"><p><span>Oracle (NYSE:ORCL - Get Free Report)</span> had its target price increased by analysts at JPMorgan Chase &amp; Co.  from $185.00 to $210.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage presently has a &#34;neutral&#34; rating on the enterprise software provider's stock. JPMorgan Chase &amp; Co.'s price target would suggest a potential downside of 12.09% from the company's previous close.</p><ul><li>3 Reasons Salesforce Is a Bargain Right Now</li></ul><p>Several other research analysts also recently issued reports on the company. CIBC  reaffirmed a &#34;buy&#34; rating on shares of Oracle in a research note on Monday, June 9th. Barclays raised their price target on shares of Oracle from $221.00 to $281.00 and gave the stock an &#34;overweight&#34; rating in a research note on Monday. Oppenheimer  reaffirmed an &#34;outperform&#34; rating on shares of Oracle in a research note on Wednesday, June 18th. Cowen  reaffirmed a &#34;buy&#34; rating on shares of Oracle in a research note on Thursday, June 12th. Finally, Westpark Capital raised their price target on shares of Oracle from $195.00 to $246.00 and gave the stock a &#34;buy&#34; rating in a research note on Thursday, June 12th. Three analysts have rated the stock with a Strong Buy rating, twenty-two have assigned  a Buy rating and nine have issued  a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and an average price target of $232.61.</p><p><b>Get Our Latest Stock Analysis on Oracle</b></p><h2>Oracle Stock Performance</h2><ul><li>4 Stocks Every AI ETF Is Buying—And They’re Not What You Think</li></ul><p>Shares of ORCL opened at $238.89 on Monday. The company has a 50-day simple moving average of $239.38 and a 200-day simple moving average of $186.73. The company has a quick ratio of 0.75, a current ratio of 0.75 and a debt-to-equity ratio of 4.07. The company has a market capitalization of $671.00 billion, a PE ratio of 54.84, a P/E/G ratio of 3.47 and a beta of 1.46. Oracle has a 52-week low of $118.86 and a 52-week high of $260.87. </p><p>Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings results on Wednesday, June 11th. The enterprise software provider reported $1.70 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.64 by $0.06. The business had revenue of $15.90 billion during the quarter, compared to the consensus estimate of $15.58 billion. Oracle had a net margin of 21.68% and a return on equity of 87.34%. The business's revenue was up 11.3% compared to the same quarter last year. During the same quarter last year, the firm posted $1.63 EPS.  Equities research analysts predict that  Oracle will post 5 earnings per share for the current fiscal year. </p><h2>Insider Transactions at Oracle</h2><ul><li>MarketBeat Week in Review – 08/11 - 08/15</li></ul><p>In other news, Director Naomi O. Seligman sold 3,303 shares of the firm's stock in a transaction that occurred on Wednesday, July 16th. The shares were sold at an average price of $233.32, for a total transaction of $770,655.96. Following the completion of the sale, the director owned 31,447 shares of the company's stock, valued at approximately $7,337,214.04. This trade represents a 9.51% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, EVP Maria Smith sold 10,000 shares of the company's stock in a transaction that occurred on Thursday, July 3rd. The shares were sold at an average price of $232.99, for a total value of $2,329,900.00. Following the sale, the executive vice president directly owned 40,807 shares in the company, valued at approximately $9,507,622.93. This represents a 19.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 444,183 shares of company stock worth $86,521,198 over the last 90 days. 42.20% of the stock is owned by corporate insiders. </p><h2>Institutional Inflows and Outflows</h2><p>A number of large investors have recently modified their holdings of ORCL. Snider Financial Group grew its holdings in  Oracle by 1.3% during the second quarter. Snider Financial Group now owns 3,204 shares of the enterprise software provider's stock valued at $701,000 after purchasing an additional 40 shares during the period.  SNS Financial Group LLC lifted its position in shares of  Oracle by 0.9% during the second quarter. SNS Financial Group LLC now owns 4,896 shares of the enterprise software provider's stock worth $1,070,000 after acquiring an additional 42 shares in the last quarter.  PKS Advisory Services LLC lifted its position in shares of  Oracle by 1.9% during the second quarter. PKS Advisory Services LLC now owns 2,211 shares of the enterprise software provider's stock worth $483,000 after acquiring an additional 42 shares in the last quarter.  Reyes Financial Architecture Inc. lifted its position in shares of  Oracle by 7.2% during the second quarter. Reyes Financial Architecture Inc. now owns 643 shares of the enterprise software provider's stock worth $141,000 after acquiring an additional 43 shares in the last quarter.  Finally, Creative Capital Management Investments LLC lifted its position in shares of  Oracle by 5.7% during the second quarter. Creative Capital Management Investments LLC now owns 798 shares of the enterprise software provider's stock worth $174,000 after acquiring an additional 43 shares in the last quarter. 42.44% of the stock is owned by institutional investors and hedge funds. </p><h2>About Oracle</h2> (Get Free Report)<p>Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Oracle</li><li>What Are Dividend Challengers?</li><li>2 Stocks That Could Rocket on a Fed Rate Cut</li><li>The Basics of Support and  Resistance</li><li>3 Fintech Stocks Beating the Market in 2025</li><li>A Deeper Look at Bid-Ask Spreads</li><li>Potential Rate Cuts Could Benefit These Firms</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU9SQ0w"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Oracle Right Now?</h2><p>Before you consider Oracle, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.</p><p>While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

ORCL

<p>JPMorgan Chase & Co. has raised its target price for Oracle (NYSE:ORCL) from $185.00 to $210.00, maintaining a "neutral" rating. This suggests a potential downside of 12.09% from Oracle's previous close. Other analysts have varied opinions, with CIBC reaffirming a "buy" rating, Barclays increasing their target to $281.00, and Westpark Capital raising it to $246.00. Currently, Oracle has a consensus rating of "Moderate Buy" with an average target of $232.61. The stock opened at $238.89, with a market cap of $671 billion and a PE ratio of 54.84.</p>

Oracle (NYSE:ORCL) Price Target Raised to $210.00